These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

467 related articles for article (PubMed ID: 10523861)

  • 1. Tumor promoter-induced ornithine decarboxylase gene expression occurs independently of AP-1 activation.
    Jansen AP; Colburn NH; Verma AK
    Oncogene; 1999 Oct; 18(42):5806-13. PubMed ID: 10523861
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibitors of both nuclear factor-kappaB and activator protein-1 activation block the neoplastic transformation response.
    Li JJ; Westergaard C; Ghosh P; Colburn NH
    Cancer Res; 1997 Aug; 57(16):3569-76. PubMed ID: 9270030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of tumor promoter 12-O-tetradecanoylphorbol-13-acetate-induced synthesis of epidermal ornithine decarboxylase messenger RNA and diacylglycerol-promoted mouse skin tumor formation by retinoic acid.
    Verma AK
    Cancer Res; 1988 Apr; 48(8):2168-73. PubMed ID: 3349487
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protein kinase Cdelta-mediated signal to ornithine decarboxylase induction is independent of skin tumor suppression.
    Wheeler DL; Reddig PJ; Dreckschmidt NE; Leitges M; Verma AK
    Oncogene; 2002 May; 21(22):3620-30. PubMed ID: 12032864
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Involvement of protein kinase C activation in ornithine decarboxylase gene expression in primary culture of newborn mouse epidermal cells and in skin tumor promotion by 12-O-tetradecanoylphorbol-13-acetate.
    Verma AK; Pong RC; Erickson D
    Cancer Res; 1986 Dec; 46(12 Pt 1):6149-55. PubMed ID: 3779635
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of tumor promoter-induced transformation by retinoids that transrepress AP-1 without transactivating retinoic acid response element.
    Li JJ; Dong Z; Dawson MI; Colburn NH
    Cancer Res; 1996 Feb; 56(3):483-9. PubMed ID: 8564958
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel transformation suppressor, Pdcd4, inhibits AP-1 transactivation but not NF-kappaB or ODC transactivation.
    Yang HS; Jansen AP; Nair R; Shibahara K; Verma AK; Cmarik JL; Colburn NH
    Oncogene; 2001 Feb; 20(6):669-76. PubMed ID: 11314000
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dominant-negative c-Jun (TAM67) target genes: HMGA1 is required for tumor promoter-induced transformation.
    Dhar A; Hu J; Reeves R; Resar LM; Colburn NH
    Oncogene; 2004 May; 23(25):4466-76. PubMed ID: 15064752
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of dominant negative Erk2 inhibits AP-1 transactivation and neoplastic transformation.
    Watts RG; Huang C; Young MR; Li JJ; Dong Z; Pennie WD; Colburn NH
    Oncogene; 1998 Dec; 17(26):3493-8. PubMed ID: 10030673
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of dominant negative Jun inhibits elevated AP-1 and NF-kappaB transactivation and suppresses anchorage independent growth of HPV immortalized human keratinocytes.
    Li JJ; Rhim JS; Schlegel R; Vousden KH; Colburn NH
    Oncogene; 1998 May; 16(21):2711-21. PubMed ID: 9652737
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AP-1 transrepressing retinoic acid does not deplete coactivators or AP-1 monomers but may target specific Jun or Fos containing dimers.
    Suzukawa K; Colburn NH
    Oncogene; 2002 Mar; 21(14):2181-90. PubMed ID: 11948401
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Celecoxib inhibits phorbol ester-induced expression of COX-2 and activation of AP-1 and p38 MAP kinase in mouse skin.
    Chun KS; Kim SH; Song YS; Surh YJ
    Carcinogenesis; 2004 May; 25(5):713-22. PubMed ID: 14729583
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Osteopontin induction is required for tumor promoter-induced transformation of preneoplastic mouse cells.
    Chang PL; Cao M; Hicks P
    Carcinogenesis; 2003 Nov; 24(11):1749-58. PubMed ID: 12919959
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pdcd4 suppresses tumor phenotype in JB6 cells by inhibiting AP-1 transactivation.
    Yang HS; Knies JL; Stark C; Colburn NH
    Oncogene; 2003 Jun; 22(24):3712-20. PubMed ID: 12802278
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibitory effect of oleanolic acid on 12-O-tetradecanoylphorbol-13-acetate-induced gene expression in mouse skin.
    Oguro T; Liu J; Klaassen CD; Yoshida T
    Toxicol Sci; 1998 Sep; 45(1):88-93. PubMed ID: 9848115
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Two novel glycosides from the fruits of Morinda citrifolia (noni) inhibit AP-1 transactivation and cell transformation in the mouse epidermal JB6 cell line.
    Liu G; Bode A; Ma WY; Sang S; Ho CT; Dong Z
    Cancer Res; 2001 Aug; 61(15):5749-56. PubMed ID: 11479211
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Xanthorrhizol inhibits 12-O-tetradecanoylphorbol-13-acetate-induced acute inflammation and two-stage mouse skin carcinogenesis by blocking the expression of ornithine decarboxylase, cyclooxygenase-2 and inducible nitric oxide synthase through mitogen-activated protein kinases and/or the nuclear factor-kappa B.
    Chung WY; Park JH; Kim MJ; Kim HO; Hwang JK; Lee SK; Park KK
    Carcinogenesis; 2007 Jun; 28(6):1224-31. PubMed ID: 17234720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of polyphenols derived from fruit of Crataegus pinnatifida on cell transformation, dermal edema and skin tumor formation by phorbol ester application.
    Kao ES; Wang CJ; Lin WL; Chu CY; Tseng TH
    Food Chem Toxicol; 2007 Oct; 45(10):1795-804. PubMed ID: 17493734
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential induction of c-fos and c-jun proto-oncogenes and AP-1 activity by tumor promoter 12-O-tetradecanoyl phorbol 13-acetate in cells at different stages of tumor promotion in vitro.
    Wu WS; Lin JK; Wu FY
    Oncogene; 1992 Nov; 7(11):2287-94. PubMed ID: 1437150
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diallyl trisulfide inhibits phorbol ester-induced tumor promotion, activation of AP-1, and expression of COX-2 in mouse skin by blocking JNK and Akt signaling.
    Shrotriya S; Kundu JK; Na HK; Surh YJ
    Cancer Res; 2010 Mar; 70(5):1932-40. PubMed ID: 20179211
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.